Utilization of Clinical Pathways Can Reduce Drug Spend Within the Oncology Care Model

PURPOSE: Reducing drug spend is one of the greatest challenges for practices participating in the Oncology Care Model (OCM). Evidence-based clinical pathways have the potential to decrease drug spend while maintaining clinical outcomes consistent with published evidence. The goal of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hertler, Andrew, Chau, Sang, Khetarpal, Rani, Bassin, Ed, Dang, Jeff, Koppel, Daniel, Damarla, Vijay, Wade, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Special Series: Science of Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224689/
https://www.ncbi.nlm.nih.gov/pubmed/32196401
http://dx.doi.org/10.1200/JOP.19.00753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224689/
https://www.ncbi.nlm.nih.gov/pubmed/32196401
http://dx.doi.org/10.1200/JOP.19.00753

Ejemplares similares